A Drug Utilisation Study of Fenfluramine in Europe

Study identification

• EU PAS number:
  EUPAS1000000529
• Study ID:
  1000000529
• Official title and acronym:
  A Drug Utilisation Study of Fenfluramine in Europe
• DARWIN EU® study:
  No
• Study countries:
  Austria

  Denmark

  European Union

  France

  Germany

  Italy

  Spain
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Actual:26/01/2023

Study start date

Actual:24/06/2024

Date of final study report

Planned:31/12/2027

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Zogenix International Ltd. (a wholly owned subsidiary of UCB Biosciences, Inc.)

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)

Other study registration identification numbers and links

EP0219